Would carnosine or a carnivorous diet help suppress aging and associated pathologies?

Annals of the New York Academy of Sciences

Volumn 1067, Issue 1, 2006, Pages 369-374

  Hipkiss, Alan R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

AGEs; Anti glycators; Carbonyls; Chelators; Glycation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOACYLHISTIDINE DIPEPTIDASE; CARBONYL DERIVATIVE; CARNOSINE; COPPER; DIPEPTIDE; ENZYME; UNCLASSIFIED DRUG; ZINC;

AGING; BIOCHEMISTRY; CARBONYL STRESS; CARNIVORY; CELL RESPIRATION; CHELATION; CONFERENCE PAPER; CROSS LINKING; DEGENERATIVE DISEASE; DIABETES MELLITUS; DIET; DIET SUPPLEMENTATION; HUMAN; NONHUMAN; OLFACTORY TRACT; OXIDATION; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION;

ANIMALIA;

EID: 33744483388     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1354.052     Document Type: Conference Paper

References (31)

1. Ahmed N. 2005. Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 67: 3 21.
2. Suji G. & S. Sivakami. 2004. Glucose, glycation and aging. Biogerontology 5: 365 373.
3. Chen F. M.A. Wollmer F. Hoerndli, et al. 2004. Role of glyoxalase 1 in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 101: 7687 7692.
4. Davydov V.V. N.M. Dobaeva & A.I. Bozhkov. 2004. Possible role of alteration of aldehyde's scavenger enzymes during aging. Exp. Gerontol 39: 11 16.
5. Kikuchi S. K. Shinpo M. Takeuchi, et al. 2003. Glycation - a sweet tempter for neuronal death. Brain Res. Rev. 41: 306 323.
6. Hipkiss A.R. 2005. Glycation, ageing and carnosine: are carnivorous diets beneficial¿ Mech. Ageing Dev. 126: 1034 1039.
7. Krajcovicova-Kudlackova M. K. Sebekova R. Schinzel, et al. 2002. Advanced glycation end products and nutrition. Physiol. Res. 51: 313 316.
8. Battah S. N. Ahmed & P.J. Thornally. 2002. Novel anti-glycation therapeutic agents: glyoxylase-1-mimetics. Int. Congress Series 1245: 107 111.
9. Brownlee M. 2001. Biochemistry and molecular biology of diabetic complications. Nature 414: 813 820.
10. Lee Y-T. C-C. Hsu M-H. Lin, et al. 2005. Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation. Eur. J. Pharmacol. 512: 145 150.
11. Shuvaev V.V. I. Laffont M. Serot, et al. 2001. Increased protein glycation in cerebrospinal fluid of Alzheimer's disease. Neurobiol. Aging 22: 397 402.
12. Pickolo M.J. Sr.., T.J. Montine V. Amarnath, et al. 2002. Carbonyl toxicology and Alzheimer's disease. Toxicol. Appl. Pharmacol. 184: 187 197.
13. Reddy V.P. M.E. Obrenovich C.S. Atwood, et al. 2002. Involvement of Maillard reactions in Alzheimer's disease. Neurotox. Res. 4: 191 209.
14. Ahmed N. U. Ahmed P.J. Thornalley, et al. 2005. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment. J. Neurochem. 92: 255 263.
15. Hipkiss A.R. 2005. Could carnosine suppress zinc-mediated proteasome inhibition and neurodegeneration¿ Therapeutic potential of a non-toxic but non-patentable dipeptide. Biogerontology 6: 147 149.
16. Preston J.E. A.R. Hipkiss D.J.T. Himsworth, et al. 1998. Toxic effects of β-amyloid (25-35) on immortalised rat brain endothelial cells: protection by carnosine, homocarnosine and β-alanine. Neurosci. Lett. 242: 105 108.
17. Munch G. S. Mayer J. Michaelis, et al. 1997. Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptide. Biochim. Biophys. Acta 1360: 17 29.
18. Kim K.S. S.Y. Choi H.Y. Kwon, et al. 2002. The ceruloplasmin and hydrogen peroxide system induces α-synuclein aggregation in vitro. Biochimie 84: 625 631.
19. Miyata T. & C. van Ypersele van Strihou. 2003. Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implications of radical scavenging and transition metal chelation in inhibition of advanced glycosylation end product formation. Arch. Biochem. Biophys. 419: 50 54.
20. Boldyrev A. E. Bulygina T. Leinsoo, et al. 2003. Protection of neuronal cells against reactive oxygen species by carnosine and related compounds. Comp. Biochem. Physiol. Part B 137: 81 88.
21. Hipkiss A.R. 2004. Is carnosine a naturally occurring suppressor of olfactory damage in olfactory neurones¿ Rejuven. Res. 7: 253 255.
22. Ghanbari H.A. K. Ghanbari P.L.R. Harris, et al. 2004. Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients. Aging Cell 3: 41 44.
23. Sassoe-Pognetto M.M. D. Cantino P. Panzanelli, et al. 1993. Presynaptic colocalization of carnosine and glutamate in olfactory neurones. Neuroreport 5: 7 10.
24. Antonini F.M. E. Petruzzi P. Pinzani, et al. 2002. The meat in the diet of aged subjects and the antioxidant effects of carnosine. Arch. Gerontol. Geriatr. Suppl. 8: 7 14.
25. Chez M.G. C.P. Buchanan & M.C. Aimonovitch. 2002. Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders. J. Child Neurol. 17: 833 837.
26. McGinnis W.R. 2004. Oxidative stress in autism. Altern. Ther. Health Med. 10: 22 36.
27. Junaid M.A. D. Kowal M. Barua, et al. 2004. Proteomic studies identified a single nucleotide polymorphism in glyoxalase 1 as autism susceptibility factor. Am. J. Med. Genet A. 131: 11 17.
28. McCarty M.F. 2005. The low-AGE content of low-fat vegan diets could benefit diabetics - though concurrent taurine supplementation may be needed to minimize endogenous AGE production. Med. Hypotheses 64: 394 398.
29. Huang Y. J. Duan H. Chen, et al. 2005. Separation and determination of carnosine-related peptides using capillary electrophoresis with laser-induced fluorescence detection. Electrophoresis 26: 593 599.
30. Ahmed N. U. Ahmed P.J. Thornalley, et al. 2005. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment. J. Neurochem. 92: 255 263.
31. Janssen B. D. Hohenadel P. Brinkkoetter, et al. 2005. Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes 54: 2320 2327.